• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer/T-cell lymphoma patients.

作者信息

Huang Dezhi, Li Fu, Lin Shijia, Xia Jing, Liu Bangdong, Li Xinlei, Ma Naya, Duan Yishuo, Zeng Yunjing, Zhou Sha, Tang Shuhan, Huang Wenqiu, Rao Lingyi, Gao Li, Li Qiong, Zhang Xi, Rao Jun

机构信息

Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, 400038, China; State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Jinfeng Laboratory, Chongqing, 401329, China.

Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, 400038, China; State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Jinfeng Laboratory, Chongqing, 401329, China; National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

出版信息

Haematologica. 2025 Jan 1;110(1):200-205. doi: 10.3324/haematol.2024.285362.

DOI:10.3324/haematol.2024.285362
PMID:39157873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694128/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/db50a3b1bed1/110200.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/f301876cb537/110200.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/268278df743d/110200.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/db50a3b1bed1/110200.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/f301876cb537/110200.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/268278df743d/110200.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a6f/11694128/db50a3b1bed1/110200.fig3.jpg

相似文献

1
A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer/T-cell lymphoma patients.基于影像学和分子参数的新型预后列线图在初诊结外自然杀伤/T细胞淋巴瘤患者中的应用
Haematologica. 2025 Jan 1;110(1):200-205. doi: 10.3324/haematol.2024.285362.
2
The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.基于控制营养状况（CONUT）评分的列线图对结外自然杀伤/T 细胞淋巴瘤患者的预后价值。
Ann Hematol. 2023 Jun;102(6):1433-1442. doi: 10.1007/s00277-023-05232-3. Epub 2023 Apr 19.
3
Nomograms based on SUVmax of F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.基于 F-FDG PET/CT 最大标准摄取值和临床参数的列线图预测初诊结外鼻型自然杀伤/T 细胞淋巴瘤患者的无进展生存和总生存。
Cancer Imaging. 2021 Jan 8;21(1):9. doi: 10.1186/s40644-020-00379-y.
4
Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.绝对淋巴细胞计数/绝对单核细胞计数比值及预后评分对鼻型结外自然杀伤/T细胞淋巴瘤患者的预后影响
Tumour Biol. 2017 May;39(5):1010428317705503. doi: 10.1177/1010428317705503.
5
Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.普拉曲沙作为一线化疗难治的晚期结外鼻型自然杀伤/T细胞淋巴瘤患者异基因造血干细胞移植的桥梁：一例报告
J Med Case Rep. 2020 Mar 17;14(1):43. doi: 10.1186/s13256-020-02363-3.
6
Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.早期结外自然杀伤/T细胞淋巴瘤患者化疗联合放疗的治疗结果及预后因素
Adv Radiat Oncol. 2024 Sep 28;9(12):101647. doi: 10.1016/j.adro.2024.101647. eCollection 2024 Dec.
7
A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.一种基于铁蛋白的新型预后模型和列线图修订风险指数可更好地对结外自然杀伤/T 细胞淋巴瘤患者进行分层。
Cancer Med. 2023 May;12(9):10660-10671. doi: 10.1002/cam4.5820. Epub 2023 Mar 16.
8
Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.结外自然杀伤/T 细胞淋巴瘤患者总生存的预后列线图。
Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):e537-e543. doi: 10.1016/j.clml.2018.08.011. Epub 2018 Aug 29.
9
Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study.上呼吸道消化道结外自然杀伤/T细胞淋巴瘤（鼻型，IE期和IIE期）总生存的预后列线图：一项基于监测、流行病学和最终结果（SEER）数据库的研究
Oncol Lett. 2019 Oct;18(4):3493-3500. doi: 10.3892/ol.2019.10719. Epub 2019 Aug 6.
10
Prognostic value of interim [F]FDG PET/CT after immunotherapy-based combinations in extranodal NK/T-cell lymphoma, nasal type.基于免疫疗法的联合治疗后，[F]FDG PET/CT中期检查对鼻型结外NK/T细胞淋巴瘤的预后价值
Eur Radiol. 2025 Jan 21. doi: 10.1007/s00330-024-11276-4.

本文引用的文献

1
Advances in single-cell RNA sequencing and its applications in cancer research.单细胞 RNA 测序技术的进展及其在癌症研究中的应用。
J Hematol Oncol. 2023 Aug 24;16(1):98. doi: 10.1186/s13045-023-01494-6.
2
The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma.循环肿瘤DNA与PINK-E联合的新型预后指数模型预测新诊断结外NK/T细胞淋巴瘤的临床结局
Hemasphere. 2022 Dec 20;7(1):e822. doi: 10.1097/HS9.0000000000000822. eCollection 2023 Jan.
3
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.
基于 Pegasparaginase 的化疗方案与基于 L-天冬酰胺酶的化疗方案治疗新诊断的晚期结外自然杀伤/T 细胞淋巴瘤的疗效和安全性：一项随机临床试验。
JAMA Oncol. 2022 Jul 1;8(7):1035-1041. doi: 10.1001/jamaoncol.2022.1968.
4
Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine.结外NK/T细胞淋巴瘤分子诊断的最新进展及其在精准医学时代的作用
Diagnostics (Basel). 2022 Feb 5;12(2):409. doi: 10.3390/diagnostics12020409.
5
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline.成熟T细胞和自然杀伤细胞淋巴瘤（不包括皮肤T细胞淋巴瘤）管理指南：英国血液学学会指南
Br J Haematol. 2022 Feb;196(3):507-522. doi: 10.1111/bjh.17951. Epub 2021 Nov 22.
6
Plasma circulating tumor DNA assessment reveals as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.血浆循环肿瘤DNA评估显示其为结外NK/T细胞淋巴瘤潜在的不良预后因素。
Biomark Res. 2020 Jul 17;8:27. doi: 10.1186/s40364-020-00205-4. eCollection 2020.
7
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.在现代化疗时代，列线图修订风险指数的验证及其与其他模型在结外鼻型 NK/T 细胞淋巴瘤中的比较：预后和临床决策的指征。
Leukemia. 2021 Jan;35(1):130-142. doi: 10.1038/s41375-020-0791-3. Epub 2020 Mar 9.
8
18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma.18F-FDG PET/CT 用于结外自然杀伤/T 细胞淋巴瘤患者的预后分层。
Clin Nucl Med. 2019 Mar;44(3):201-208. doi: 10.1097/RLU.0000000000002440.
9
Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.18F-FDG PET/CT标准化摄取值在结外鼻型NK/T细胞淋巴瘤患者中的预后意义：一项多中心回顾性分析
Am J Otolaryngol. 2018 Jan-Feb;39(1):1-5. doi: 10.1016/j.amjoto.2017.10.009. Epub 2017 Oct 12.
10
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.非蒽环类药物治疗后自然杀伤细胞淋巴瘤的预后指数：一项多中心回顾性分析。
Lancet Oncol. 2016 Mar;17(3):389-400. doi: 10.1016/S1470-2045(15)00533-1. Epub 2016 Feb 10.